Why is 3B Blackbio falling/rising?

As of 04-Jul, 3B Blackbio DX Ltd's stock price is rising, currently at 1,570.65, reflecting an increase of 61.7 or 4.09%. The stock has shown a strong performance today, outperforming its sector by 4.12% and achieving a consecutive gain over the last two days with a total return of 7.8%. It reached an intraday high of Rs 1580, indicating positive momentum. Despite this, the stock's delivery volume has decreased significantly, falling by 41.57% against the 5-day average, which may suggest a decline in investor participation. Over the past week, the stock has gained 10.07%, although it has experienced a decline of 5.10% over the last month. Positive factors contributing to the stock's rise include a low debt-to-equity ratio and healthy long-term growth, with operating profit increasing at an annual rate of 41.02%. However, the company has faced challenges, such as flat results in March and a high valuation compared to peers, which could temper investor enthusiasm.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has declined by 0.74% over the past week. While 3B Blackbio has outperformed the benchmark significantly in the short term, it has underperformed over the longer term, with a year-to-date decline of 20.62% compared to the Sensex's increase of 6.77%. This divergence highlights the stock's volatility and the potential concerns surrounding its valuation and investor confidence, particularly given the negligible stake held by domestic mutual funds, which may indicate a lack of comfort with the current price levels.